The potential of cord blood to replenish young immune cells against cancer
Open Access
- 20 June 2021
- journal article
- review article
- Published by Wiley in Aging and Cancer
- Vol. 2 (1-2), 36-44
- https://doi.org/10.1002/aac2.12032
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Human umbilical cord blood plasma alleviates age-related olfactory dysfunction by attenuating peripheral TNF-α expressionBMB Reports, 2019
- Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseasesJournal of Cellular and Molecular Medicine, 2018
- The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE)Ageing Research Reviews, 2018
- Human umbilical cord plasma proteins revitalize hippocampal function in aged miceNature, 2017
- Immunosenescence and vaccine failure in the elderly: Strategies for improving responseImmunology Letters, 2014
- Immunosenescence and age-related viral diseasesScience China Life Sciences, 2013
- A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampusAGE, 2012
- Immunosenescence of ageingThe Journal of Pathology, 2007
- Immunosenescence and VaccinationImmunity & Ageing, 2005
- Allogeneic Hematopoietic Cell Transplantation as Immunotherapy for Solid TumorsJournal of Immunotherapy, 2005